Free public records show ProSomnus Sleep Technologies in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by ProSomnus Sleep Technologies or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by ProSomnus Sleep Technologies, of 4 in all
Source: ClinicalTrials.gov, Studies with ProSomnus Sleep Technologies (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
3 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies ProSomnus Sleep Technologies leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with ProSomnus Sleep Technologies or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show ProSomnus Sleep Technologies: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets ProSomnus Sleep Technologies is in.
Stories on the topics ProSomnus Sleep Technologies works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
ReadSearch all reports for ProSomnus Sleep Technologies All companies